This inventor holds 2 USPTO granted patents. Top assignee: Boehringer Ingelheim (Canada) Ltd.. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2004
Title: Dale Cameron: Innovator in Hepatitis C Research
Introduction
Dale Cameron is a notable inventor based in Rosemère, Canada. He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for Hepatitis C. With a total of 2 patents to his name, Cameron's work is recognized for its potential impact on public health.
Latest Patents
Cameron's latest patents include groundbreaking work on Hepatitis C inhibitor peptides. His patents focus on Hepatitis C inhibitor tri-peptides, specifically a racemate, diastereoisomer, and optical isomer of a compound of formula (I). These innovations are crucial in the ongoing battle against Hepatitis C, offering new avenues for treatment.
Career Highlights
Cameron is currently employed at Boehringer Ingelheim (Canada) Ltd., where he continues to push the boundaries of medical research. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.
Collaborations
Some of Cameron's notable coworkers include Dominik M Wernic and Montse Llinas-Brunet. Their collective expertise contributes to the innovative environment at Boehringer Ingelheim, fostering advancements in medical science.
Conclusion
Dale Cameron's contributions to Hepatitis C research exemplify the importance of innovation in medicine. His patents and ongoing work at Boehringer Ingelheim highlight his commitment to improving health outcomes for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile